Abstract
A quick-release formulation of bromocriptine [Cycloset]* appears to be a promising new treatment modality for type 2 diabetes mellitus (T2DM),
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
